Entries of van der Heijden, Michiel S. on the publication server
 | Up a level |
Number of items: 13.
2023
Gil-Jimenez, Alberto, van Dorp, Jeroen 
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
Gil-Jimenez, Alberto, van Dorp, Jeroen, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17].
European Urology 83 (6), e165.
Fulltext not available.
van Dorp, Jeroen , Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick , Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G. , Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg and van der Heijden, Michiel S.
(2023)
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nature Medicine 29 (3), pp. 588-592.
Fulltext not available.
, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick , Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G. , Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg and van der Heijden, Michiel S.
(2023)
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nature Medicine 29 (3), pp. 588-592.
Fulltext not available.
Claps, Francesco , van de Kamp, Maaike W., Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F., Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Otto, Wolfgang, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Trombetta, Carlo, Eckstein, Markus , Mertens, Laura S., Burger, Maximilian, Soorojebally, Yanish, Wullich, Bernd, Bartoletti, Riccardo, Radvanyi, François, Pavan, Nicola, Sirab, Nanour, Mir, M. Carmen, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Bussani, Rossana, Allory, Yves and van Rhijn, Bas W.G.
(2023)
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
BJU International 132 (2), pp. 170-180.
Fulltext not available.
, van de Kamp, Maaike W., Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F., Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Otto, Wolfgang, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Trombetta, Carlo, Eckstein, Markus , Mertens, Laura S., Burger, Maximilian, Soorojebally, Yanish, Wullich, Bernd, Bartoletti, Riccardo, Radvanyi, François, Pavan, Nicola, Sirab, Nanour, Mir, M. Carmen, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Bussani, Rossana, Allory, Yves and van Rhijn, Bas W.G.
(2023)
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
BJU International 132 (2), pp. 170-180.
Fulltext not available.
Einerhand, Sarah M.H., Voskuilen, Charlotte S., van de Putte, Elies E. Fransen, Donswijk, Maarten L. , Bruining, Annemarie, van der Heijden, Michiel S., Mertens, Laura S., Hendricksen, Kees, Vegt, Erik and van Rhijn, Bas W.G.
(2023)
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer.
Bladder Cancer 9 (1), pp. 49-57.
Fulltext not available.
, Bruining, Annemarie, van der Heijden, Michiel S., Mertens, Laura S., Hendricksen, Kees, Vegt, Erik and van Rhijn, Bas W.G.
(2023)
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer.
Bladder Cancer 9 (1), pp. 49-57.
Fulltext not available.
Mellema, Jan-Jaap J. , van Rhijn, Bas W.G. and van der Heijden, Michiel S.
(2023)
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer.
Current Opinion in Urology 33 (5), pp. 404-411.
Fulltext not available.
, van Rhijn, Bas W.G. and van der Heijden, Michiel S.
(2023)
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer.
Current Opinion in Urology 33 (5), pp. 404-411.
Fulltext not available.
2022
Einerhand, Sarah M. H., van Dijk, Nick, van Dorp, Jeroen, de Feijter, Jeantine M., van Montfoort, Maurits L., van de Kamp, Maaike W., Schaake, Eva E., Boellaard, Thierry N., Hendricksen, Kees, van der Heijden, Michiel S. and van Rhijn, Bas W. G.
(2022)
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum‐based chemotherapy for locally advanced (Stage III ) urothelial cancer.
International Journal of Cancer.
Fulltext not available.
van Dorp, Jeroen, van Montfoort, Maurits L., van Dijk, Nick, Hofland, Ingrid, de Feijter, Jeantine M., Bergman, Andries M., Hendricksen, Kees, van der Poel, Henk G., van Rhijn, Bas W.G. and van der Heijden, Michiel S.
(2022)
A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer.
Clinical Genitourinary Cancer 20 (2), e173-e179.
Fulltext not available.
Mertens, Laura S. , Claps, Francesco , Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F. , Zwarthoff, Ellen C. , Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H. , Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, Peters, Dennis, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, van der Schoot, Deric K.E., Wullich, Bernd, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanour, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Allory, Yves, Zuiverloon, Tahlita C.M. and van Rhijn, Bas W.G.
(2022)
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
Urologic Oncology: Seminars and Original Investigations 40 (3), 110.e1-110.e9.
Fulltext not available.
, Claps, Francesco , Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F. , Zwarthoff, Ellen C. , Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H. , Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, Peters, Dennis, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, van der Schoot, Deric K.E., Wullich, Bernd, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanour, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Allory, Yves, Zuiverloon, Tahlita C.M. and van Rhijn, Bas W.G.
(2022)
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
Urologic Oncology: Seminars and Original Investigations 40 (3), 110.e1-110.e9.
Fulltext not available.
2021
van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, van Montfoort, Maurits L., Einerhand, Sarah, Jonkman, Lars, Voskuilen, Charlotte S., Peters, Dennis, Sanders, Joyce, Lubeck, Yoni, Broeks, Annegien, Hooijberg, Erik, Vis, Daniel J., van den Broek, Maries, Wessels, Lodewyk F. A., van Rhijn, Bas W. G. and van der Heijden, Michiel S.
(2021)
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
Frontiers in Immunology 12.
Fulltext not available.
2020
van Rhijn, Bas W.G., Mertens, Laura S., Mayr, Roman, Bostrom, Peter J., Real, Francisco X. , Zwarthoff, Ellen C., Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H., Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, van der Heijden, Michiel S., Jewett, Michael A.S., Marquez, Mirari, Stoehr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, Roshani, Hossain, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanor, Pouessel, Damien, Wullich, Bernd, van der Kwast, Theo H., Malats, Núria, Hartmann, Arndt, Allory, Yves and Zuiverloon, Tahlita C.M.
(2020)
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†.
European Urology 78 (5), pp. 682-687.
Fulltext not available.
, Zwarthoff, Ellen C., Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H., Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, van der Heijden, Michiel S., Jewett, Michael A.S., Marquez, Mirari, Stoehr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, Roshani, Hossain, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanor, Pouessel, Damien, Wullich, Bernd, van der Kwast, Theo H., Malats, Núria, Hartmann, Arndt, Allory, Yves and Zuiverloon, Tahlita C.M.
(2020)
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†.
European Urology 78 (5), pp. 682-687.
Fulltext not available.
van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina , Hendricksen, Kees, Smit, Laura A., de Feijter, Jeantine M., van Montfoort, Maurits L., van Rooijen, Charlotte, Peters, Dennis, Broeks, Annegien, van der Poel, Henk G., Bruining, Annemarie, Lubeck, Yoni, Sikorska, Karolina, Boellaard, Thierry N., Kvistborg, Pia, Vis, Daniel J., Hooijberg, Erik, Schumacher, Ton N., van den Broek, Maries, Wessels, Lodewyk F. A., Blank, Christian U., van Rhijn, Bas W. and van der Heijden, Michiel S.
(2020)
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
Nature Medicine 26 (12), pp. 1839-1844.
Fulltext not available.
, Hendricksen, Kees, Smit, Laura A., de Feijter, Jeantine M., van Montfoort, Maurits L., van Rooijen, Charlotte, Peters, Dennis, Broeks, Annegien, van der Poel, Henk G., Bruining, Annemarie, Lubeck, Yoni, Sikorska, Karolina, Boellaard, Thierry N., Kvistborg, Pia, Vis, Daniel J., Hooijberg, Erik, Schumacher, Ton N., van den Broek, Maries, Wessels, Lodewyk F. A., Blank, Christian U., van Rhijn, Bas W. and van der Heijden, Michiel S.
(2020)
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
Nature Medicine 26 (12), pp. 1839-1844.
Fulltext not available.
Voskuilen, Charlotte S., van de Kamp, Maaike W., Schuring, Nannet, Mertens, Laura S., Noordzij, Arjen, Pos, Floris, van Rhijn, Bas W.G., van der Heijden, Michiel S. and Schaake, Eva E.
(2020)
Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil.
Radiotherapy and Oncology 150, pp. 275-280.
Fulltext not available.